CD8A and central nervous system cancer: The results demonstrated that an anti-mouse CD8 cDb labeled with 89Zr ([89Zr]-malDFO-169 cDb) specifically localized in orthotopic syngeneic glioma tumors in mice treated with the M002 oHSV compared to saline controls and contralateral brain tissue.